OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 22 citing articles:

Discovery of novel pyrazole based Urea/Thiourea derivatives as multiple targeting VEGFR-2, EGFRWT, EGFRT790M tyrosine kinases and COX-2 Inhibitors, with anti-cancer and anti-inflammatory activities
Wael A.A. Fadaly, Mohamed T. M. Nemr, Nesma M. Kahk
Bioorganic Chemistry (2024) Vol. 147, pp. 107403-107403
Closed Access | Times Cited: 22

Design, synthesis, antineoplastic activity of new pyrazolo[3,4-d]pyrimidine derivatives as dual CDK2/GSK3β kinase inhibitors; molecular docking study, and ADME prediction
Mohamed T. M. Nemr, Ahmed Elshewy, Mohammed L. Ibrahim, et al.
Bioorganic Chemistry (2024) Vol. 150, pp. 107566-107566
Closed Access | Times Cited: 15

Exploring the antineoplastic potential of novel NSAID derivatives in combatting mammary tumorigenesis: a comprehensive review
Rashmi Dewangan, Nidhi Agrawal, Sanjay Kumar Lanjhiyana, et al.
Medicinal Chemistry Research (2025)
Closed Access | Times Cited: 1

Optimization of pyrazole/1,2,4-triazole as dual EGFR/COX-2 inhibitors: Design, synthesis, anticancer potential, apoptosis induction and cell cycle analysis
Nesma M. Kahk, Fatma El Zahraa Ammar Mohamed, Marwa M. Abdelhakeem, et al.
European Journal of Medicinal Chemistry (2025), pp. 117340-117340
Closed Access

New amidrazone analogs as multi-kinase inhibitors: in-silico and biological investigation as an anticancer agent
Almeqdad Y. Habashneh, Mahmoud A. Al-Sha’er, Sanaa K. Bardaweel
Medicinal Chemistry Research (2025)
Closed Access

Semi-synthesis and biological activities of heterocyclic compounds containing camphor
Zeinab S. Hamza, Wael N. Hozzein, Khaled El‐Adl, et al.
RSC Advances (2025) Vol. 15, Iss. 17, pp. 13199-13213
Open Access

Design, Synthesis and Biological Evaluation of Phenoxyacetic Acid derivatives Linked to Pyrazole Scaffold as PPAR-α/γ Agonists and COX-2 Inhibitors with Dual Antidiabetic/Anti-inflammatory Activities
Wael A.A. Fadaly, Dina M.E. Amin, Rania B. Bakr, et al.
Journal of Molecular Structure (2025) Vol. 1340, pp. 142578-142578
Closed Access

Design and synthesis of new pyrazole hybrids linked to oxime and nitrate moieties as COX-2, EGFRL858R/T790M inhibitors and nitric oxide donors with dual anti-inflammatory/anti-proliferative activities
Wael A.A. Fadaly, Mohamed T. M. Nemr, Abeer M. Abd El-Hameed, et al.
Bioorganic Chemistry (2025) Vol. 161, pp. 108563-108563
Closed Access

Recent achievements in molecular insights, anticancer activities, and comparative structure activity relationships of thiazolidin-4-one derivatives as EGFR inhibitors (2019-present)
Wessam I. Elsisi, Riham F. George, Yasmin M. Syam, et al.
Bioorganic & Medicinal Chemistry (2025), pp. 118244-118244
Closed Access

Design, synthesis and biological evaluation of thienopyridine derivatives as c-Met kinase inhibitors
Tianyu Xie, Wenbo Hu, Lin You, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 3

Green design and synthesis of some novel thiazolidinone appended benzothiazole–triazole hybrids as antimicrobial agents
Bhaskar Dwivedi, Diksha Bhardwaj, Deepika Choudhary
RSC Advances (2024) Vol. 14, Iss. 12, pp. 8341-8352
Open Access | Times Cited: 2

An overview on pharmaceutical applications of phosphodiesterase enzyme 5 (PDE5) inhibitors
Mohamed T. M. Nemr, Mohamad Abdelaziz, Mohamed Teleb, et al.
Molecular Diversity (2024)
Open Access | Times Cited: 2

Development of safe and antioxidant COX-2 inhibitors; Synthesis, molecular docking analysis and biological evaluation of novel pyrrolizine 5-carboxamides
Eman K. A. Abdelall, Heba A.H. Elshemy, John N. Philoppes, et al.
Bioorganic Chemistry (2024) Vol. 143, pp. 107098-107098
Closed Access | Times Cited: 2

Discovery of novel 4-trifluoromethyl-2-anilinoquinoline derivatives as potential anti-cancer agents targeting SGK1
Guangcan Xu, Lanlan Li, Mengfan Lv, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 1

Synthesis, biological activities and mechanistic studies of C20-ketone pachysandra alkaloids as anti-hepatocellular carcinoma agents
Jinfeng Zhao, Jing Bai, Xiang Yu, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 1

Whole-volume histogram analysis of spectral-computed tomography iodine maps characterizes HER2 expression in gastric cancer
Weiling Zhang, Jing Sun, Rongfang Huang, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 38, pp. 4211-4220
Closed Access | Times Cited: 1

Insight into the therapeutic potential of pyrazole‐thiazole hybrids: A comprehensive review
Garima Sumran, Manisha Sharma, Ranjana Aggarwal
Archiv der Pharmazie (2024)
Closed Access | Times Cited: 1

New chalcone incorporated structurally modified pyridine‐pyrimidine derivatives as anticancer agents: Their design, synthesis, and in‐vitro evaluation
Swarupa Ketha, Chithaluri Sudhakar, Shashikala Kethireddy, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 12
Closed Access

Page 1

Scroll to top